tanshinone has been researched along with propofol in 2 studies
| Studies (tanshinone) | Trials (tanshinone) | Recent Studies (post-2010) (tanshinone) | Studies (propofol) | Trials (propofol) | Recent Studies (post-2010) (propofol) |
|---|---|---|---|---|---|
| 1,445 | 10 | 1,033 | 16,827 | 5,188 | 6,805 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, H; Jiang, S; Lai, L; Liu, Y; Wang, G; Wang, Q; Wang, Y; Yu, G; Zhu, X | 1 |
| Cheng, X; Hao, H; Liu, F; Liu, M; Ma, Y; Wang, G; Wang, H; Wang, Q; Wu, M; Wu, X | 1 |
2 other study(ies) available for tanshinone and propofol
| Article | Year |
|---|---|
Regioselective glucuronidation of tanshinone iia after quinone reduction: identification of human UDP-glucuronosyltransferases, species differences, and interaction potential.
Topics: Abietanes; Animals; Dogs; Glucuronides; Glucuronosyltransferase; Humans; Isoenzymes; Isomerism; Kinetics; Liver; Male; Mice; Mice, Inbred ICR; Mycophenolic Acid; NAD(P)H Dehydrogenase (Quinone); Phenanthrenes; Propofol; Rats; Rats, Sprague-Dawley; Species Specificity | 2010 |
UDP-glucuronosyltransferase 1A compromises intracellular accumulation and anti-cancer effect of tanshinone IIA in human colon cancer cells.
Topics: Abietanes; Anesthetics, Intravenous; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Colonic Neoplasms; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glucuronosyltransferase; Humans; NAD(P)H Dehydrogenase (Quinone); Propofol; Reactive Oxygen Species; UDP-Glucuronosyltransferase 1A9 | 2013 |